Older adults assigned to a cognitive behavioral therapy for insomnia had no increases over 2 years in the expression of the gene for p16INK4a, a marker of cellular senescence, in peripheral blood mononuclear cells. The gene discussed is CDKN2A; the disease is insomnia measurement.